Colitis
26 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Gastroenteritis
Narrower: Colitis, Ulcerative 23
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| AC-101 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Atorvastatin calcium trihydrate for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bezlotoxumab for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Duvakitug for colitis, ulcerative | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Emvistegrast for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal Microbial Transplantation for colitis, ulcerative | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal microbiota for colitis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Golimumab for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Guselkumab for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Infliximab for colitis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| INT-210 Capsule for colitis, ulcerative | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| JNJ-78934804 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mirikizumab for colitis, ulcerative | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Obefazimod for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PALI-2108 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Phentermine-Topiramate for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo-to-match emvistegrast + Emvistegrast for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| single FMT for colitis, ulcerative | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| SPY001 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY001 + SPY002 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY001 + SPY003 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY002 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY002 + SPY003 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY003 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Vedolizumab for colitis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vedolizumab for colitis, ulcerative | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.